Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2380)	4/16/1999 3:38:00 PM
From: quidditch	Read Replies (1) of 10280

Peter: Thanks for the DD. I am an SEC practitioner and know nothing of the custom and practice inside the FDA. Absent a closing of the positions of the agency and SEPR through correspondence invited (demanded) by the examiner, will the existence of this letter and the (according to the FDA's perspective) unwarranted, aggressive posture taken by the Company influence the course of future approvals/labeling discussions? Reading the letter naked, without the results from the trial (except as included in the examiner's letter), it would seem that SEPR took some liberties based on a "fair" read of results. For SEPR's initial independently developed and marketed drug, I wonder if management will rethink its orientation. Regards. Liacos_samui

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next